Overall cost-effectiveness of a tumour agnostic therapy, informative or useless? An evaluation based on cost-effectiveness modelling in different solid tumour types [breast cancer, lung cancer, and colorectal cancer]

Additional Metadata
Keywords	cost-effectiveness analysis;tumour agnostic;Larotrectinib
Thesis Advisor	Gils, C.W.M. van
Persistent URL	hdl.handle.net/2105/62459
Series	Master Health Economics, Policy and Law
Organisation	Erasmus School of Health Policy & Management
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Azzouz, S. (2021, August 30). Overall cost-effectiveness of a tumour agnostic therapy, informative or useless? An evaluation based on cost-effectiveness modelling in different solid tumour types [breast cancer, lung cancer, and colorectal cancer]. Master Health Economics, Policy and Law. Retrieved from http://hdl.handle.net/2105/62459

Publication